Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipeline

Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.

Related Content:

ASCRSVideosConferencesDry EyeRetinaGlaucomaTechnologyTherapeutics DMESurgery

Safety data for at-home subcutaneous injection option for treatment of wet AMD, DME

Understanding the biological causes and cell types that lead to one of the leading causes of irreversible blindness worldwide could benefit treatment in patients

Aerie Pharmaceuticals doses first participant in COMET-2 study of dry eye candidate